Cencora's Ameer Ali on the operational lift behind the 12-digit NDC shift, the readiness gap across manufacturers and what's at stake for product flow if systems aren't ready in time.
Ameer Ali
Advertisement
Ameer Ali is senior director of manufacturer operations & data services at
Cencora.
Articles by Ameer Ali
In the final installment of his interview with Pharmaceutical Commerce, Cencora's Ameer Ali outlines how supply chain stakeholders should prepare systems, processes and trading partners for the shift to NDC-12.
Cencora's Ameer Ali explains why trading partners' systems, not the NDC-12 deadline itself, determine whether product keeps moving through the supply chain during the transition.
Cencora's Ameer Ali explains how the shift to NDC-12 is reshaping supply chain systems and why readiness still varies widely across manufacturers.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Inside Cencora's Approach to AI-Driven Demand Sensing
2
Pharma Pulse: DHL's New Cold Chain Corridors and Walmart's $0 Prescription Tier
3
What AI Changes, and Doesn’t, in Exception Handling
4
BMS’s Kevin Cook on Moving CMO Partnerships Beyond Transactions
5